Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Tenon Medical, Inc. (TNON : NSDQ)
 
 • Company Description   
Tenon Medical Inc. is a medical device company which developed a proprietary, U.S. Food and Drug Administration cleared surgical implant system for sacroiliac joint fixation/fusion surgery. Tenon Medical Inc. is based in LOS GATOS, CA.

Number of Employees: 26

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.72 Daily Weekly Monthly
20 Day Moving Average: 69,878 shares
Shares Outstanding: 11.57 (millions)
Market Capitalization: $8.30 (millions)
Beta: 1.28
52 Week High: $1.74
52 Week Low: $0.64
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.98% -16.28%
12 Week -16.27% -22.59%
Year To Date -24.59% -30.93%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
104 COOPER COURT
-
LOS GATOS,CA 95032
USA
ph: 408-649-5760
fax: -
tenon@mzgroup.us http://www.tenonmed.com
 
 • General Corporate Information   
Officers
Steven M. Foster - Chief Executive Officer and President; Director
Richard Ferrari - Executive Chairman of the Board
Kevin Williamson - Chief Financial Officer; Secretary
Richard Ginn - Chief Operations Officer and Director
Ivan Howard - Director

Peer Information
Tenon Medical, Inc. (ABMD)
Tenon Medical, Inc. (DMDS)
Tenon Medical, Inc. (CPWY.)
Tenon Medical, Inc. (EQUR)
Tenon Medical, Inc. (ECIA)
Tenon Medical, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 88066N303
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/12/26
Share - Related Items
Shares Outstanding: 11.57
Most Recent Split Date: 9.00 (0.13:1)
Beta: 1.28
Market Capitalization: $8.30 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/12/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 1.81
EPS Growth
vs. Year Ago Period: 69.31%
vs. Previous Quarter: -40.91%
Sales Growth
vs. Year Ago Period: 89.94%
vs. Previous Quarter: -6.89%
ROE
03/31/26 - -907.60
12/31/25 - -409.16
09/30/25 - -409.04
ROA
03/31/26 - -110.17
12/31/25 - -110.06
09/30/25 - -114.60
Current Ratio
03/31/26 - 1.03
12/31/25 - 2.11
09/30/25 - 2.15
Quick Ratio
03/31/26 - -
12/31/25 - 1.78
09/30/25 - 1.70
Operating Margin
03/31/26 - -270.09
12/31/25 - -318.36
09/30/25 - -396.26
Net Margin
03/31/26 - -270.09
12/31/25 - -318.36
09/30/25 - -396.26
Pre-Tax Margin
03/31/26 - -270.09
12/31/25 - -318.36
09/30/25 - -396.26
Book Value
03/31/26 - -0.10
12/31/25 - 0.18
09/30/25 - 0.19
Inventory Turnover
03/31/26 - 1.65
12/31/25 - 1.71
09/30/25 - 1.89
Debt-to-Equity
03/31/26 - -
12/31/25 - 0.00
09/30/25 - 0.00
Debt-to-Capital
03/31/26 - 0.00
12/31/25 - 0.00
09/30/25 - 0.00
 

Powered by Zacks Investment Research ©